EDGAR Filing Documents for 0001387131-19-001719

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

SEC Accession No. 0001387131-19-001719

Filing Date

2019-03-04

Accepted

2019-03-04 17:26:39

Documents

Period of Report

2015-02-28

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	plsi-10ka_022815.htm	10-K/A	600678
8	GRAPHIC	plsi001.jpg	GRAPHIC	7262
9	GRAPHIC	plsi002.jpg	GRAPHIC	5780
	Complete submission text file	0001387131-19-001719.txt		3126782

Data Files

Seq	Description	Document	Type	Size
2	XBRL INSTANCE DOCUMENT	plsi-20150228.xml	EX-101.INS	382605
3	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	plsi-20150228.xsd	EX-101.SCH	39120
4	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	plsi-20150228_cal.xml	EX-101.CAL	44504
5	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	plsi-20150228_def.xml	EX-101.DEF	181175
6	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	plsi-20150228_lab.xml	EX-101.LAB	274741
7	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	plsi-20150228_pre.xml	EX-101.PRE	241707

Mailing Address 3000 LAWRENCE STREET DENVER CO 80205

Business Address 3000 LAWRENCE STREET DENVER CO 80205 1.720.699.7222

Phoenix Life Sciences International Limited. (Filer) CIK: 0001493212 (see all company filings)